This article was originally published in The Gray Sheet
Submits 510(k) submission to FDA for the Selecta 7000 selective laser trabeculotherapy (SLT) laser system for treatment of open angle glaucoma. SLT lowers intraocular pressure using a laser to increase the fluid outflow of the eye, the firm explains. The procedure provides an alternative to current pharmacological solutions and laser techniques. Coherent estimates that as many as 300,000 U.S. patients are currently eligible for SLT
You may also be interested in...
Unilever North America agrees SmartyPant, founded in 2011 to create a comprehensive supplement made from premium ingredients to support the wellbeing needs of children and adults. Kind, fully owned by Mars, has an agreement to acquire family-owned Nature's Bakery which offers snacks including fig bars and other soft-baked foods.
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.